Stock Scorer

ImmunityBio, Inc. (IBRX) · Insider trading

What ImmunityBio's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$0
0 insiders, 0 trades
Sold, 12 months
$9.51M
3 insiders, 100% under a plan
Net, 12 months
−$9.51M
bought less sold
Latest filing
2026-10-06
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2025-01 2025-07 2026-01: $1.53M sold 2026-01 2026-02: $2.93M sold 2026-06: $1.23M sold 2026-07: $2.68M sold 2026-07 2026-10: $1.12M sold
Bought Sold Largest month: $2.93M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Simon Barry J.Director – $4.41M 8 2026-10-05 2,777,788
Selecky ChristobelDirector – $3.00M 6 2026-07-01 0
Cohen CherylDirector – $2.10M 2 2026-10-02 100,309

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-10-05 Simon Barry J.Director Saleplan 25,000 10.75 $268,760 2,777,788 Form 4
2026-10-02 Cohen CherylDirector Saleplan 81,056 10.50 $851,088 100,309 Form 4
2026-07-02 Cohen CherylDirector Saleplan 131,210 9.50 $1.25M 125,386 Form 4
2026-07-01 Selecky ChristobelDirector Saleplan 159,478 9.02 $1.44M 0 Form 4
2026-06-30 Selecky ChristobelDirector Saleplan 1,000 9.00 $9,000 0 Form 4
2026-06-29 Selecky ChristobelDirector Saleplan 95,722 9.01 $862,455 0 Form 4
2026-06-24 Simon Barry J.Director Saleplan 25,000 7.88 $197,000 2,802,788 Form 4
2026-06-04 Simon Barry J.Director Saleplan 23,033 7.18 $165,377 2,827,788 Form 4
2026-02-24 Simon Barry J.Director Saleplan 75,000 12.01 $900,750 2,850,821 Form 4
2026-02-23 Simon Barry J.Director Saleplan 165,000 10.25 $1.69M 2,925,821 Form 4
2026-02-23 Selecky ChristobelDirector Saleplan 25,000 10.00 $250,000 0 Form 4
2026-02-20 Simon Barry J.Director Saleplan 10,000 9.25 $92,500 3,081,604 Form 4
2026-01-20 Simon Barry J.Director Saleplan 76,967 6.54 $503,364 3,166,604 Form 4
2026-01-20 Simon Barry J.Director Saleplan 75,000 7.88 $591,000 3,091,604 Form 4
2026-01-20 Selecky ChristobelDirector Saleplan 25,000 7.51 $187,750 0 Form 4
2026-01-16 Selecky ChristobelDirector Saleplan 50,000 5.00 $250,000 0 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

32 × option exercise19 × shares withheld for tax3 × conversion
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-10-02 Cohen CherylDirector Option exercise M +55,979 2.98 181,365 Form 4
2026-07-02 Cohen CherylDirector Option exercise M +55,979 2.98 256,596 Form 4
2026-07-01 Selecky ChristobelDirector Option exercise M +35,064 2.98 35,064 Form 4
2026-07-01 Selecky ChristobelDirector Option exercise M +124,414 2.99 159,478 Form 4
2026-06-30 Selecky ChristobelDirector Option exercise M +700 2.98 700 Form 4
2026-06-30 Selecky ChristobelDirector Option exercise M +300 2.99 1,000 Form 4
2026-06-29 Selecky ChristobelDirector Option exercise M +32,173 2.98 32,173 Form 4
2026-06-29 Selecky ChristobelDirector Option exercise M +33,549 2.99 65,722 Form 4
2026-06-29 Selecky ChristobelDirector Option exercise M +30,000 2.84 95,722 Form 4
2026-03-31 Soon-Shiong PatrickDirector, See remarks, 10% owner Conversion C +4,606,596 5.43 251,018,873 Form 4
2026-02-23 Selecky ChristobelDirector Option exercise M +25,000 2.98 25,000 Form 4
2026-02-22 Soon-Shiong PatrickDirector, See remarks, 10% owner Option exercise M +114,329 – 29,816,081 Form 4
2026-02-22 Soon-Shiong PatrickDirector, See remarks, 10% owner Shares withheld for tax F −58,170 8.70 29,757,911 Form 4
2026-02-22 Lauer Regan JChief Accounting Officer Option exercise M +4,065 – 117,548 Form 4
2026-02-22 Lauer Regan JChief Accounting Officer Shares withheld for tax F −1,673 8.70 115,875 Form 4
2026-02-22 Simon Barry J.Director Option exercise M +15,243 – 3,096,847 Form 4
2026-02-22 Simon Barry J.Director Shares withheld for tax F −6,026 8.70 3,090,821 Form 4
2026-02-22 Adcock RichardDirector, CEO & President Option exercise M +152,439 – 637,904 Form 4
2026-02-22 Adcock RichardDirector, CEO & President Shares withheld for tax F −77,560 8.70 560,344 Form 4
2026-02-22 Sachs David C.Chief Financial Officer Option exercise M +40,650 – 320,825 Form 4
2026-02-22 Sachs David C.Chief Financial Officer Shares withheld for tax F −20,682 8.70 300,143 Form 4
2026-02-10 Soon-Shiong PatrickDirector, See remarks, 10% owner Option exercise M +274,122 – 29,820,312 Form 4
2026-02-10 Soon-Shiong PatrickDirector, See remarks, 10% owner Shares withheld for tax F −118,560 6.93 29,701,752 Form 4
2026-02-10 Lauer Regan JChief Accounting Officer Option exercise M +5,482 – 115,740 Form 4
2026-02-10 Lauer Regan JChief Accounting Officer Shares withheld for tax F −2,257 6.93 113,483 Form 4
2026-02-10 Adcock RichardDirector, CEO & President Option exercise M +274,122 – 625,513 Form 4
2026-02-10 Adcock RichardDirector, CEO & President Shares withheld for tax F −140,048 6.93 485,465 Form 4
2026-02-10 Sachs David C.Chief Financial Officer Option exercise M +82,236 – 322,818 Form 4
2026-02-10 Sachs David C.Chief Financial Officer Shares withheld for tax F −42,643 6.93 280,175 Form 4
2026-01-20 Selecky ChristobelDirector Option exercise M +25,000 2.98 25,000 Form 4
2026-01-16 Selecky ChristobelDirector Option exercise M +50,000 2.98 50,000 Form 4
2025-12-31 Adcock RichardDirector, CEO & President Option exercise M +34,483 – 368,901 Form 4
2025-12-31 Adcock RichardDirector, CEO & President Shares withheld for tax F −17,510 1.98 351,391 Form 4
2025-12-31 Sachs David C.Chief Financial Officer Option exercise M +30,397 – 256,017 Form 4
2025-12-31 Sachs David C.Chief Financial Officer Shares withheld for tax F −15,435 1.98 240,582 Form 4
2025-02-22 Simon Barry J.Director Option exercise M +15,243 – 3,249,024 Form 4
2025-02-22 Simon Barry J.Director Shares withheld for tax F −5,453 3.42 3,243,571 Form 4
2025-02-22 Adcock RichardDirector, CEO & President Option exercise M +152,439 – 412,585 Form 4
2025-02-22 Adcock RichardDirector, CEO & President Shares withheld for tax F −78,167 3.42 334,418 Form 4
2025-02-22 Sachs David C.Chief Financial Officer Option exercise M +40,650 – 241,480 Form 4
2025-02-22 Sachs David C.Chief Financial Officer Shares withheld for tax F −15,860 3.42 225,620 Form 4
2025-02-22 Soon-Shiong PatrickDirector, See remarks, 10% owner Option exercise M +114,329 – 29,588,261 Form 4
2025-02-22 Soon-Shiong PatrickDirector, See remarks, 10% owner Shares withheld for tax F −42,071 3.42 29,546,190 Form 4
2025-02-22 Lauer Regan JChief Accounting Officer Option exercise M +4,065 – 111,927 Form 4
2025-02-22 Lauer Regan JChief Accounting Officer Shares withheld for tax F −1,669 3.42 110,258 Form 4
2025-01-22 Simon Barry J.Director Option exercise M +110,020 2.00 3,233,781 Form 4
2024-12-31 Sachs David C.Chief Financial Officer Option exercise M +30,397 – 216,235 Form 4
2024-12-31 Sachs David C.Chief Financial Officer Shares withheld for tax F −15,405 2.56 200,830 Form 4
2024-12-31 Adcock RichardDirector, CEO & President Option exercise M +34,483 – 277,621 Form 4
2024-12-31 Adcock RichardDirector, CEO & President Shares withheld for tax F −17,475 2.56 260,146 Form 4
2024-12-15 Lauer Regan JChief Accounting Officer Option exercise M +21,031 – 115,365 Form 4
2024-12-15 Lauer Regan JChief Accounting Officer Shares withheld for tax F −7,503 2.87 107,862 Form 4
2024-12-10 Soon-Shiong PatrickDirector, See remarks, 10% owner Conversion C +103,710,088 1.94 232,937,105 Form 4
2024-12-10 Soon-Shiong PatrickDirector, See remarks, 10% owner Conversion C +13,475,172 2.28 246,412,277 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

ImmunityBio's scores and multiples ›